Evidence map›Paper›PMID 35497859›Full record

ArticleRSC advances2020

Ameliorative effect of urolithin A on d-gal-induced liver and kidney damage in aging mice

Peng Chen, Jiexin Lei, Fuchao Chen, Benhong Zhou

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Effects of supplementalAnimal biotechnology · 2024
    Article
  12. Multi-Protective Effects of Petunidin-3-O-(International journal of molecular sciences · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Bioinformation · 2024
    Article
  17. Article
  18. Article
  19. Ultrasonic treatment ofFood science & nutrition · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Peng ChenDepartment of Pharmacy, Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. China benhongzh@whu.edu.cn +86 15335898431.ORCID https://orcid.org/0000-0003-4936-2064
Jiexin LeiDepartment of Endocrinology, Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. China.
Fuchao ChenDepartment of Pharmacy, Dongfeng Hospital, Hubei University of Medicine Shiyan Hubei 442008 P. R. China.
Benhong ZhouDepartment of Pharmacy, Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. China benhongzh@whu.edu.cn +86 15335898431.ORCID https://orcid.org/0000-0002-6129-0182
Wuhan University · CNHubei University of Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urolithin A, a metabolite produced by human colon microflora from ellagic acid and related compounds, has been reported to have antioxidant, anti-inflammatory and antiapoptotic properties. The present study investigates the protective effects of urolithin A (Uro A) on d-galactose (d-gal)-induced liver and kidney injury and the possible mechanisms in mice. In this study, we first investigated the antioxidant ability of Uro A

Identifiers

PMID35497859
PMCPMC9049876
OpenAlexW3006921319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.